Portfolio, Press Investors Poured Nearly US$8B into Synthetic Biology Last Year – Twist Bioscience is Leading the Field Posted on March 21, 2022March 21, 2022 by iGlobe Partners Orbital Therapeutics Acquired by Bristol-Myers
